2018
DOI: 10.3390/medsci6010012
|View full text |Cite
|
Sign up to set email alerts
|

Alpha-Difluoromethylornithine, an Irreversible Inhibitor of Polyamine Biosynthesis, as a Therapeutic Strategy against Hyperproliferative and Infectious Diseases

Abstract: The fluorinated ornithine analog α-difluoromethylornithine (DFMO, eflornithine, ornidyl) is an irreversible suicide inhibitor of ornithine decarboxylase (ODC), the first and rate-limiting enzyme of polyamine biosynthesis. The ubiquitous and essential polyamines have many functions, but are primarily important for rapidly proliferating cells. Thus, ODC is potentially a drug target for any disease state where rapid growth is a key process leading to pathology. The compound was originally discovered as an antican… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
50
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 43 publications
(52 citation statements)
references
References 108 publications
0
50
1
Order By: Relevance
“…Polyamines are involved in many cellular processes, including protein synthesis, regulation of gene expression, regulation of ion channels, cell cycling, and many others (20)(21)(22)(23)(24)(25)(26)(27). Synthesis of the three biogenic polyamines putrescine, spermidine, and spermine, can be targeted with drugs such as difluoromethylornithine (DFMO) (28). DFMO is FDA approved and is currently used to treat trypanosomiasis (29)(30)(31) and hirsutism (32).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Polyamines are involved in many cellular processes, including protein synthesis, regulation of gene expression, regulation of ion channels, cell cycling, and many others (20)(21)(22)(23)(24)(25)(26)(27). Synthesis of the three biogenic polyamines putrescine, spermidine, and spermine, can be targeted with drugs such as difluoromethylornithine (DFMO) (28). DFMO is FDA approved and is currently used to treat trypanosomiasis (29)(30)(31) and hirsutism (32).…”
mentioning
confidence: 99%
“…DFMO is FDA approved and is currently used to treat trypanosomiasis (29)(30)(31) and hirsutism (32). DFMO specifically inhibits ODC1, a rate-limiting enzyme at the beginning of the polyamine synthesis pathway (28). We previously demonstrated that RNA viruses utilize cellular polyamines for their replication (33,34).…”
mentioning
confidence: 99%
“…As chemoprevention involves the long-term administration of a natural or synthetic compound to healthy individuals with the goal of preventing or delaying the onset of disease, the minimization of potential side effects is critical. The overall safety of DFMO has been well established, and it currently retains orphan drug FDA status with approval for the treatment of human African trypanosomiasis and female hirsutism [ 53 ]. Although its long-term use was initially associated with a dose-related, reversible ototoxicity, anemia, and mild gastrointestinal side effects, dose de-escalation studies focusing on prevention rather than cancer treatment revealed that DFMO dosage could be reduced to that which minimizes these off-target effects while effectively reducing colorectal mucosa polyamine levels in patients susceptible to colorectal cancer [ 13 , 54 ].…”
Section: Discussionmentioning
confidence: 99%
“…Where I pC refers to the cathodic peak current, n is the number of electron transfer (n = 1), A represents the surface area of the electrode (cm 2 ), D 0 is the diffusion coefficient ð7:6 � 10 À 6 cm 2 s À 1 Þ, u is the scan rate and C 0 is the concentration of K 3 [Fe(CN) 6 ] ð5 � 10 À 6 mol:cm À 3 Þ. Subsequently, from the slope of plotting I pC versus square root of scan rate u 1 = 2 !…”
Section: Electrochemical Performance Of the Modified Electrodementioning
confidence: 99%
“…DFMO is the only new treatment since last seven decades, for the second stage African Trypanosomiasis (HAT, also known as sleeping sickness) [4,5]. In addition, it has been applied for treatment of the facial hirsutism in women [6]. Since the 1980s, studies have shown that DFMO can aid in some chemoprevention by decreasing the polyamine levels [7].…”
Section: Introductionmentioning
confidence: 99%